RTL 02 -- The latest news from MDedge Hematology/Oncology

MRI IDs significant prostate cancer, drug interactions to avoid in GI cancers, ctDNA clearance tracks with NSCLC survival, COVID symptoms persist

The latest news from MDedge Hematology/Oncology:
In this episode:
Subscribe to Blood & Cancer:
Apple Podcasts, Spotify, Google Podcasts

1. MRI reliably identifies significant prostate cancer

2. Drug-drug interactions to avoid in patients with GI cancer

3. ctDNA clearance tracks with PFS in NSCLC subtype

4. COVID-19 symptoms can linger for months

Interact with us on Twitter: @MDedgeHemOnc